声带下上皮下地塞米松注射的全身效应与吸收
这项前瞻性对照前后对比研究比较了声带下上皮下类固醇注射(VFSI)与声带填充(VFA)后的全身变化。14例接受0.8-2 mg地塞米松VFSI,36例接受VFA。VFSI后第1天血清皮质醇从基线304.6 ± 116.6 nmol/L显著降至48.1 ± 41.8 nmol/L(p = 0.001),第7天恢复至303.7 ± 78.7 nmol/L;唾液皮质醇呈相似模式,第3天显著恢复(p = 0.001)。VFA组血清和唾液皮质醇及白细胞计数无显著变化。两种操作均未观察到C反应蛋白或患者生理参数的显著变化。结论表明VFSI后地塞米松存在全身吸收,引起急性下丘脑-垂体-肾上腺(HPA)轴抑制,术后第3天恢复正常。
要点
- VFSI后第1天血清皮质醇从基线304.6 ± 116.6 nmol/L显著降至48.1 ± 41.8 nmol/L(p = 0.001)。
- VFSI后唾液皮质醇呈相似模式,第3天显著恢复(p = 0.001)。
- VFA组血清和唾液皮质醇及白细胞计数无显著变化。
核心结论
- VFSI后地塞米松存在全身吸收,引起急性HPA轴抑制,术后第3天恢复正常。
研究设计与样本
- 前瞻性、对照前后对比研究;14例接受VFSI(地塞米松0.8-2 mg),36例接受VFA。
主要发现
- VFSI组血清皮质醇基线304.6 ± 116.6 nmol/L,第1天降至48.1 ± 41.8 nmol/L(p = 0.001),第7天恢复至303.7 ± 78.7 nmol/L。
- VFSI组唾液皮质醇呈相似模式,第3天显著恢复(p = 0.001)。
- VFSI组白细胞计数受外源性类固醇全身吸收影响,第7天恢复正常。
- VFA组血清和唾液皮质醇及白细胞计数无显著变化。
- 两种操作均未观察到C反应蛋白或患者生理参数的显著变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/HYPOTHESIS: To compare the systemic changes following two office-based procedures-subepithelial vocal fold steroid injections (VFSI) and vocal fold augmentation (VFA), and to characterize the magnitude and chronicity of the effects observed. STUDY DESIGN: Prospective, controlled before-after comparative study. METHODS: Patients prospectively underwent VFSI with 0.8-2 mg of dexamethasone or VFA. Serum cortisol, white cell count (WCC), and C-reactive protein (CRP) were measured at day 0 (pre-procedure), 1 and 7. Salivary cortisol was measured at baseline and daily for 7 days post-procedure. RESULTS: Fourteen patients underwent VFSI and 36 VFA. At baseline serum cortisol measured 304.6 ± 116.6 nmol/L and fell significantly to 48.1 ± 41.8 nmol/L 1 day following dexamethasone injection (p = 0.001) and recovered by day 7 to 303.7 ± 78.7 nmol/L. Salivary cortisol demonstrated a similar pattern with significant recovery demonstrated by day 3 (p = 0.001). White cell counts were affected by the systemic absorption of exogenous steroid and normalized by day 7. Patients who underwent VFA demonstrated no significant change in their serum or salivary cortisol and no significant change in their WCC. No significant changes in CRP or patient's physiological parameters were observed in either procedure. CONCLUSION: Our findings demonstrate systemic absorption of dexamethasone following VFSI, with acute hypothalamic-pituitary-adrenal (HPA) axis suppression which normalizes day 3 post-procedurally. LEVEL OF EVIDENCE: 3 Laryngoscope, 135:801-808, 2025.
引用
- Alwan M, Phyland DJ, Smith JA, et al. Systemic Effects and Absorption of Subepithelial Dexamethasone Vocal Fold Injections. Laryngoscope. 2024. PMID: 39400353. doi:10.1002/lary.31824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。